EDGAR Filing Documents for 0001144204-11-003811

Form 8-K - Current report:

SEC Accession No. 0001144204-11-003811

Filing Date

2011-01-25

Accepted

2011-01-25 06:03:29

Documents

Period of Report

2011-01-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		v208927_8k.htm	8-K	45265
2		v208927_ex4-1.htm	EX-4.1	112593
3		v208927_ex10-1.htm	EX-10.1	224827
4		v208927_ex99-1.htm	EX-99.1	17246
	Complete submission text file	0001144204-11-003811.txt		401488

Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2

Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)